Is NANO.PA undervalued or overvalued?
As of 2025-03-25, the Intrinsic Value of Nanobiotix SA (NANO.PA) is 16.13 EUR. This NANO.PA valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 3.46 EUR, the upside of Nanobiotix SA is 366.50%. This means that NANO.PA is undervalued by 366.50%.
The range of the Intrinsic Value is 3.57 - 24.93 EUR
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (571.22) - (51.53) | (88.36) | -2655.4% |
| DCF (Growth 10y) | (32.90) - (253.19) | (48.89) | -1513.7% |
| DCF (EBITDA 5y) | 3.57 - 24.93 | 16.13 | 366.5% |
| DCF (EBITDA 10y) | (1.02) - 26.67 | 13.73 | 297.0% |
| Fair Value | -3.55 - -3.55 | -3.55 | -202.70% |
| P/E | (5.26) - (7.03) | (6.89) | -299.2% |
| EV/EBITDA | (1.85) - 9.46 | 3.01 | -12.9% |
| EPV | (7.88) - (13.44) | (10.66) | -408.3% |
| DDM - Stable | (7.24) - (104.07) | (55.66) | -1709.5% |
| DDM - Multi | (10.69) - (124.75) | (20.04) | -679.4% |
| Market Cap (mil) | 162.98 |
| Beta | 1.48 |
| Outstanding shares (mil) | 47.13 |
| Enterprise Value (mil) | 143.59 |
| Market risk premium | 5.82% |
| Cost of Equity | 7.74% |
| Cost of Debt | 6.02% |
| WACC | 7.30% |